Disease, Disability, and Injury Prevention and Control, 34750 [2010-14772]

Download as PDF 34750 Federal Register / Vol. 75, No. 117 / Friday, June 18, 2010 / Notices regarding whether the applicant for extension acted with due diligence during the regulatory review period by December 15, 2010. To meet its burden, the petition must contain sufficient facts to merit an FDA investigation. (See H. Rept. 857, part 1, 98th Cong., 2d sess., pp. 41–42, 1984.) Petitions should be in the format specified in 21 CFR 10.30. Comments and petitions should be submitted to the Division of Dockets Management. Three copies of any mailed information are to be submitted, except that individuals may submit one copy. Comments are to be identified with the docket number found in brackets in the heading of this document. Comments and petitions may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday. Dated: May 10, 2010. Jane A. Axelrad, Associate Director for Policy, Center for Drug Evaluation and Research. Agenda items are subject to change as priorities dictate. Contact Person for More Information: J. Felix Rogers, Ph.D., M.P.H., NCIPC/ERPO, CDC, 4770 Buford Highway, NE., M/S F63, Atlanta, Georgia 30341–3724, Telephone (770) 488–4334. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: June 10, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2010–14772 Filed 6–17–10; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [FR Doc. 2010–14814 Filed 6–17–10; 8:45 am] BILLING CODE 4160–01–S [Docket No. FDA–2010–N–0295 ] DEPARTMENT OF HEALTH AND HUMAN SERVICES Web-Based Public Meeting To Discuss Issues Related to the Development of an Enforcement Action Plan; Request for Data, Information, and Views Centers for Disease Control and Prevention AGENCY: HHS. Disease, Disability, and Injury Prevention and Control srobinson on DSKHWCL6B1PROD with NOTICES Special Emphasis Panel (SEP): Cooperative Agreement Program for the National Academic Centers of Excellence in Youth Violence Prevention (U01), Funding Opportunity Announcement (FOA) CE10–004, Initial Review In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting: Times and Dates: 8 a.m.–5 p.m., July 22, 2010 (Closed). 8 a.m.–5 p.m., July 23, 2010 (Closed). Place: Embassy Suites Atlanta—Buckhead, 3285 Peachtree Road, NE., Atlanta, Georgia 30305, Telephone: 404–261–7733. Status: The meetings will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5, U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Section 10(d) of Public Law 92–463. Matters to be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to ‘‘Cooperative Agreement Program for the National Academic Centers of Excellence in Youth Violence Prevention (U01), FOA CE10–004.’’ VerDate Mar<15>2010 16:17 Jun 17, 2010 Jkt 220001 Food and Drug Administration, ACTION: Notice of Web-based public meeting; request for data, information, and views. SUMMARY: The Food and Drug Administration (FDA), Center for Tobacco Products is announcing that it is hosting a Web-based public meeting to discuss issues regarding the development of an enforcement action plan to enforce restrictions on promotion and advertising of menthol and other cigarettes to youth, including youth in minority communities. FDA is seeking participation in the Web-based public meeting and data, information, and views from all interested parties, including, but not limited to, public health organizations, minority community groups and leaders, other stakeholders with demonstrated expertise and experience in serving minority communities, groups serving youth, patient groups, advertising agencies, the regulated industry, and other interested parties. This Web-based public meeting and the data, information, and views we receive are intended to help FDA in developing an enforcement action plan. FDA is seeking input on a number of specific issues, but is interested in other pertinent information as well. PO 00000 Frm 00068 Fmt 4703 Sfmt 4703 DATES: The Web-based public meeting will be held on June 30, 2010, from 9 a.m. to 5 p.m. EDT. Persons interested in participating in the Web-based public meeting must submit written or electronic registration by close of business on June 23, 2010. Submit written and electronic data, information, and views by August 2, 2010. ADDRESSES: Submit data, information, and views electronically to https:// www.regulations.gov. Submit written data, information, and views to the Division of Dockets Management (HFA– 305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Submit electronic registration to CTPCompliance@fda.hhs.gov. Submit written registration to Anthony W. Lee, Center for Tobacco Products, Food and Drug Administration, 9200 Corporate Blvd., Rockville, MD 20850. FOR FURTHER INFORMATION CONTACT: Anthony W. Lee, Center for Tobacco Products, Food and Drug Administration, 9200 Corporate Blvd., Rockville, MD 20850–3229, 877–287– 1373, email: AnthonyW.Lee@fda.hhs.gov. SUPPLEMENTARY INFORMATION: I. Background The Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act) (Public Law 111–31; 123 Stat. 1776) was enacted on June 22, 2009, providing FDA with the authority to regulate tobacco products in order to protect the public health generally and to reduce tobacco use by minors. Tobacco products are responsible for more than 440,000 deaths each year in the United States (Ref. 1). In enacting the Tobacco Control Act, Congress found, among other things, that the use of tobacco products by children is a pediatric disease and virtually all new users of tobacco products are under the minimum legal age to purchase such products (sections 2(1) and (4) of the Tobacco Control Act). Advertising, marketing, and promotion of tobacco products have been ‘‘especially directed to attract young persons to use tobacco products, and these efforts have resulted in increased use of such products by youth’’ (section 2(15) of the Tobacco Control Act). Additionally, the rates of tobacco use and tobacco-related mortality are higher among certain racial and ethnic groups, including American Indian and Alaska Natives, and African-American men. As the National Cancer Institute (NCI) noted in Monograph 19, ‘‘[t]argeting of various population groups—including * * * specific racial and ethnic E:\FR\FM\18JNN1.SGM 18JNN1

Agencies

[Federal Register Volume 75, Number 117 (Friday, June 18, 2010)]
[Notices]
[Page 34750]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-14772]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control

    Special Emphasis Panel (SEP): Cooperative Agreement Program for the 
National Academic Centers of Excellence in Youth Violence Prevention 
(U01), Funding Opportunity Announcement (FOA) CE10-004, Initial Review
    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting:

    Times and Dates: 8 a.m.-5 p.m., July 22, 2010 (Closed). 8 a.m.-5 
p.m., July 23, 2010 (Closed).
    Place: Embassy Suites Atlanta--Buckhead, 3285 Peachtree Road, 
NE., Atlanta, Georgia 30305, Telephone: 404-261-7733.
    Status: The meetings will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5, 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Section 10(d) of Public Law 
92-463.
    Matters to be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``Cooperative Agreement Program for the National 
Academic Centers of Excellence in Youth Violence Prevention (U01), 
FOA CE10-004.''
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: J. Felix Rogers, Ph.D., 
M.P.H., NCIPC/ERPO, CDC, 4770 Buford Highway, NE., M/S F63, Atlanta, 
Georgia 30341-3724, Telephone (770) 488-4334. The Director, 
Management Analysis and Services Office has been delegated the 
authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities 
for both CDC and the Agency for Toxic Substances and Disease 
Registry.

    Dated: June 10, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2010-14772 Filed 6-17-10; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.